熱門資訊> 正文

MacroGenics任命新首席执行官

2025-08-14 04:24

MacroGenics (NASDAQ:MGNX) has appointed Eric Risser as president, chief executive officer, and board member effective August 13, 2025.
Risser has served as the company's chief operating officer since 2022.
Risser succeeds Dr. Scott Koenig as CEO.
Source: Press release

More on MacroGenics

MacroGenics: Working On That Road To Recovery
MacroGenics signs financial deal with Sagard for retifanlimab
Seeking Alpha’s Quant Rating on MacroGenics
Historical earnings data for MacroGenics
Financial information for MacroGenics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。